Cargando…

Prevalence and prognostic implications of reduced left ventricular ejection fraction among patients with STEMI in India

AIMS: To describe clinical characteristics and outcomes for those with STEMI and reduced left ventricular ejection fraction (LVEF) in low‐income and middle‐income countries (LMICs). METHODS AND RESULTS: Adults presenting with STEMI to two government‐owned tertiary care centres in Delhi, India were p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hendrickson, Michael J., Arora, Sameer, Vaduganathan, Muthiah, Fonarow, Gregg C., MP, Girish, Bansal, Ankit, Batra, Vishal, Kunal, Shekhar, Bhatt, Deepak L., Gupta, Mohit, Qamar, Arman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773730/ https://www.ncbi.nlm.nih.gov/pubmed/35950269 http://dx.doi.org/10.1002/ehf2.14055

Ejemplares similares

Missed Opportunities for Screening and Management of Dysglycemia among Patients Presenting with Acute Myocardial Infarction in North India: The Prospective NORIN STEMI Registry
por: Ostrominski, John W., et al.
Publicado: (2022)

Clinical Profiles, Outcomes, and Sex Differences of Patients With STEMI: Findings From the NORIN-STEMI Registry
por: Qamar, Arman, et al.
Publicado: (2023)

Reply: Underutilization of Fibrinolysis Despite Timely Arrival in STEMI: A Missed Opportunity!
por: Bhatia, Kirtipal, et al.
Publicado: (2023)

Left ventricular function assessment after aortic and renal intervention in Takayasu arteritis by speckle tracking echocardiography: A pilot study
por: Mor, Sudhir, et al.
Publicado: (2022)

Design and rationale of the North Indian ST‐Segment Elevation Myocardial Infarction Registry: A prospective cohort study
por: Arora, Sameer, et al.
Publicado: (2019)

Amyloidosis and 30-Day Outcomes Among Patients With Heart Failure: A Nationwide Readmissions Database Study
por: Arora, Sameer, et al.
Publicado: (2020)

Bradyarrhythmias in patients with COVID-19: A case series
por: Gupta, Mohit D., et al.
Publicado: (2020)

Long-Term Assessment of Thin-Strut BioMime Coronary Stent System in Real-World Population at Single-Center: A Retrospective Observational Study
por: Meennahalli Palleda, Girish, et al.
Publicado: (2023)

Matrix metalloproteinases and their gene polymorphism in young ST-segment elevation myocardial infarction
por: Basia, Deepak, et al.
Publicado: (2022)

Impact of Diabetes on Outcomes in Patients Hospitalized With Acute Myocardial Infarction: Insights From the Atherosclerosis Risk in Communities Study Community Surveillance
por: Jain, Vardhmaan, et al.
Publicado: (2023)

Psychosocial stress and well-being in patients presenting with acute myocardial infarction in a tertiary care center
por: Gupta, Mohit D., et al.
Publicado: (2023)

Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction
por: Ostrominski, John W., et al.
Publicado: (2022)

Novel lipid biomarkers and associated gene polymorphism in young ST-segment elevation myocardial infarction
por: Muheeb, Ghazi, et al.
Publicado: (2023)

Manual Thrombectomy in Myocardial Infarction: Aspiring for Better
por: Vaduganathan, Muthiah, et al.
Publicado: (2015)

Trends, Management, and Outcomes of Acute Myocardial Infarction Hospitalizations With In‐Hospital‐Onset Versus Out‐of‐Hospital Onset: The ARIC Study
por: Caughey, Melissa C., et al.
Publicado: (2021)

Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021
por: Jain, Vardhmaan, et al.
Publicado: (2021)

Fifteen‐Year Trends in Management and Outcomes of Non–ST‐Segment–Elevation Myocardial Infarction Among Black and White Patients: The ARIC Community Surveillance Study, 2000–2014
por: Arora, Sameer, et al.
Publicado: (2018)

Sodium–glucose co‐transporter 2 inhibitors as an early, first‐line therapy in patients with heart failure and reduced ejection fraction
por: Tomasoni, Daniela, et al.
Publicado: (2022)

Susceptibility of CTLA-4 −1661A/G polymorphism towards severity of rheumatic heart disease
por: Bansal, Ankit, et al.
Publicado: (2021)

Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection Fraction
por: Brownell, Nicholas K., et al.
Publicado: (2022)

de Winter sign–A STEMI Equivalent
por: Mahajan, Kunal, et al.
Publicado: (2018)

Effect of government-issued state of emergency and reopening orders on cardiovascular hospitalizations during the COVID-19 pandemic
por: Arora, Sameer, et al.
Publicado: (2021)

Reply: Are We Missing Something in the Management of Acute Coronary Syndromes in COVID-19-Negative Patients?
por: Bhatt, Ankeet S., et al.
Publicado: (2020)

Use of Hydralazine‐Isosorbide Dinitrate Combination in African American and Other Race/Ethnic Group Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction
por: Golwala, Harsh B., et al.
Publicado: (2013)

Out-of-Pocket Costs for SGLT-2 (Sodium-Glucose Transport Protein-2) Inhibitors in the United States
por: Aggarwal, Rahul, et al.
Publicado: (2021)

Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019
por: Duvalyan, Angela, et al.
Publicado: (2021)

Evaluation of systemic inflammatory and thrombotic markers of cardiovascular risk among young Indian oral tobacco users
por: Zutshi, Dhananjay V., et al.
Publicado: (2020)

Heart rate variability as a marker of cardiovascular dysautonomia in post-COVID-19 syndrome using artificial intelligence
por: Shah, Bhushan, et al.
Publicado: (2022)

The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction
por: Brownell, Nicholas K, et al.
Publicado: (2021)

Association of the New Peer Group–Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program
por: McCarthy, Cian P., et al.
Publicado: (2019)

Artificial intelligence in cardiology: The past, present and future
por: Gupta, Mohit D., et al.
Publicado: (2022)

Wake Forest University long‐term follow‐up of type 2 myocardial infarction: The Wake‐Up T2MI Registry
por: Jogu, Hanumantha R., et al.
Publicado: (2019)

Role of ApoE gene polymorphism and nonconventional biochemical risk factors among very young individuals (aged less than 35 years) presenting with acute myocardial infarction
por: Gupta, Mohit D., et al.
Publicado: (2018)

Left ventricular function and coronary microcirculation in patients with mild reduced ejection fraction after STEMI
por: Ma, Yuliang, et al.
Publicado: (2022)

Innovation in Ambulatory Care of Heart Failure in the Era of Coronavirus Disease 2019
por: Leiva, Orly, et al.
Publicado: (2020)

Impact of COVID-19 vaccination on mortality after acute myocardial infarction
por: Gupta, Mohit D., et al.
Publicado: (2023)

Initiation, Continuation, or Withdrawal of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction
por: Gilstrap, Lauren G., et al.
Publicado: (2017)

The study of novel inflammatory markers in takayasu arteritis and its correlation with disease activity
por: Pathadan, Antony P., et al.
Publicado: (2021)

COVID 19-related burnout among healthcare workers in India and ECG based predictive machine learning model: Insights from the BRUCEE- Li study
por: Gupta, Mohit D., et al.
Publicado: (2021)

Correction: Left ventricular function and coronary microcirculation in patients with mild reduced ejection fraction after STEMI
por: Ma, Yuliang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_13j55997k70mobb0lqaijq3ial